In a nutshell This study examined older patients with Hodgkin lymphoma (HL) to understand how other serious health conditions affect their diagnosis and treatment. The authors found that patients with more serious illnesses were more likely to be diagnosed with advanced HL and had limited treatment options. Some background Treatment options for...
Read More
In a nutshell This study examined whether there is a link between the type of non-Hodgkin’s lymphoma (NHL) and the development of secondary cancer due to certain infections. The authors concluded that patients with diffuse large B-cell lymphoma (DLBCL) or marginal zone lymphoma (MZL) may be at risk for developing a second type of...
Read More
In a nutshell This study looked at the risk of reactivating hepatitis B (HBV) infection in patients with lymphoma treated with obinutuzumab (Gazyva) or rituximab (Rituxan). Researchers found that HBV infection was reactivated in some of these patients but treatment options are available. Some background Lymphoma is a cancer of the immune system....
Read More
